CDKN2B-AS1 and lung adenocarcinoma: For functional investigations, Wang et al demonstrated that LINC01207 promotes cell proliferation of LAD cells [29]; Xu et al. found that lncRNA ANRIL acts as an oncogene and contributes to paclitaxel resistance of lung adenocarcinoma A549 cells [30].